Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M807Revenue $M263Net Margin (%)-8.0Z-Score3.3
Enterprise Value $M737EPS $-0.3Operating Margin %-7.2F-Score3
P/E(ttm))0Cash Flow Per Share $0.0Pre-tax Margin (%)-7.6Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %0Quick Ratio2.1Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %0Current Ratio3.1Lower Leverage y-yN
Price/Cash Flow364y-y EBITDA Growth Rate %-50.0ROA % (ttm)-7.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-11.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M61.4ROI % (ttm)-7.0Gross Margin Increase y-yY

Gurus Latest Trades with NXTM

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NXTMJohn Burbank 2012-12-31 Sold Out -0.09%$10.61 - $13.73
($11.63)
$ 1312%Sold Out0
NXTMJohn Burbank 2012-09-30 Buy 0.09%$12.47 - $17.04
($14.28)
$ 13-9%New holding, 150000 sh.150,000
NXTMRon Baron 2012-06-30 Sold Out -0.02%$14.94 - $19.44
($16.42)
$ 13-21%Sold Out0
NXTMRon Baron 2012-03-31 Buy 0.02%$16.55 - $21.54
($17.89)
$ 13-27%New holding, 176418 sh.176,418
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NXTM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NXTM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Turk Joseph E JrPresident 2014-09-24Sell3,550$13.34-1.87 view
Turk Joseph E JrPresident 2014-09-19Sell1,500$14-6.5 view
Burbank Jeffrey HCEO 2014-09-19Sell2,416$14-6.5 view
Hershberger KevinChief Accounting Officer 2014-09-10Sell843$13.58-3.61 view
Burbank Jeffrey HCEO 2014-09-08Sell2,322$14-6.5 view
Turk Joseph E JrPresident 2014-09-08Sell1,500$14-6.5 view
Turk Joseph E JrPresident 2014-08-27Sell2,550$13.060.23 view
Swan Winifred LSVP and General Counsel 2014-08-15Sell2,500$13.6-3.75 view
Hershberger KevinChief Accounting Officer 2014-08-11Sell843$13.79-5.08 view
Turk Joseph E JrPresident 2014-08-07Sell1,500$14-6.5 view

Press Releases about NXTM :

    Quarterly/Annual Reports about NXTM:

    News about NXTM:

    Articles On GuruFocus.com
    Weekly 3-Year Low Highlights: MFLX, NXTM, CVRR, CMLP Nov 10 2013 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Mar 18 2011 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Mar 18 2011 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Feb 18 2011 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Feb 18 2011 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Jan 21 2011 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Jan 20 2011 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 13,710 Shares Dec 17 2010 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 12,000 Shares Dec 16 2010 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 13,710 Shares Dec 16 2010 

    More From Other Websites
    NxStage Announces FDA Clearance of Single Needle Technology Sep 16 2014
    NxStage Patients Participate in 257-Mile Tour DaVita Bike Ride Sep 10 2014
    NxStage Kidney Care Opens New Orlando Florida Dialysis Center Aug 20 2014
    NXSTAGE MEDICAL, INC. Financials Aug 15 2014
    Allan J. Collins, M.D., to join NxStage as Senior Medical Advisor Aug 12 2014
    NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 07 2014
    NXSTAGE MEDICAL, INC. Files SEC form 10-Q, Quarterly Report Aug 07 2014
    NxStage Reports Record Second Quarter 2014 Financial Results And Increases Full-Year Revenue... Aug 07 2014
    Q2 2014 NxStage Medical, Inc. Earnings Release - Before Market Open Aug 07 2014
    NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference Aug 01 2014
    NxStage® to Report Second Quarter 2014 Financial Results Jul 17 2014
    NxStage Drives to Educate Kidney Patients Jul 16 2014
    NxStage Kidney Care Hosts Grand Opening Celebration Of New State-Of-The-Art Dialysis Center In... Jul 08 2014
    NxStage Joins Patients in Celebrating Independence Jul 03 2014
    NxStage Medical reiterated Outperform after CMS rule at William Blair Jul 03 2014
    NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Jun 16 2014
    Avid Motorcyclist and NxStage Patient Reclaims His Life Jun 12 2014
    NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers May 28 2014
    Flexibility of Home Hemodialysis with NxStage System One Allows Patient to Achieve Life Milestone May 19 2014
    NxStage to Present at the William Blair Growth Stock Conference May 15 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK